Pantoprazol Krka (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Krka, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and adolescents.

GNH USA supplies Pantoprazol Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Krka is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of the esophageal lining. - Erosive esophagitis: accelerates mucosal healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors. - Peptic ulcer disease (duodenal and gastric ulcers): supports ulcer healing and prevents relapse.

Pantoprazol Krka may cause a range of adverse reactions. Most are mild and reversible, but some require prompt medical attention.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, often transient. - Abdominal pain: cramping or discomfort. - Nausea: feeling of queasiness. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Acute interstitial nephritis: kidney inflammation with reduced urine output. - Severe hypersensitivity: rash, angioedema, or anaphylaxis. - Osteoporotic fractures: increased risk with long‑term use. - Low magnesium (hypomagnesemia): muscle weakness, tremor, or cardiac arrhythmia.

When prescribing Pantoprazol Krka, clinicians should consider several safety aspects: - Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Monitor long‑term use: evaluate bone health and magnesium levels periodically. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Elderly patients: start at the lowest effective dose and monitor for adverse events. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazol Krka can affect the pharmacokinetics of several medicines. Awareness of key interactions helps maintain therapeutic effectiveness.

Major Interactions (Avoid): - Antifungal azoles (e.g., ketoconazole, itraconazole): reduced absorption leading to loss of antifungal efficacy. - HIV protease inhibitors (e.g., atazanavir, nelfinavir): decreased plasma concentrations and possible treatment failure.

Moderate Interactions (Monitor Closely): - Clopidogrel: diminished antiplatelet effect, consider alternative antiplatelet therapy. - Warfarin: potential increase in INR, monitor coagulation parameters. - Methotrexate (high dose): reduced renal clearance, watch for toxicity. - Digoxin: modest increase in serum levels, assess for signs of digoxin toxicity.